Guidelines on viral hepatitis

This practical guideline establishes definitions for “contact”, “contact person”, “contact tracing” and other associated...

These guidelines outline a public health approach to strengthening and expanding HIV testing services (HTS). They present and discuss key updates to...

In 2022, WHO published the Consolidated guidelines on HIV, viral hepatitis and STI prevention, diagnosis, treatment and care for key populations. These...

In 2022, WHO published the Consolidated guidelines on HIV, viral hepatitis and STI prevention, diagnosis, treatment and care for key populations. These...

In 2022, WHO published the Consolidated guidelines on HIV, viral hepatitis and STI prevention, diagnosis, treatment and care for key populations....

This publication summarizes the approach proposed by WHO to collect, analyse, report, disseminate and use strategic information on viral hepatitis at the...

This policy brief provides an overview and the summary of recommendations of the new 2024 Guidelines for the prevention, diagnosis, care and treatment...

Hepatitis B (HBV) infection is a major public health problem and cause of chronic liver disease. The 2024 HBV guidelines provide updated evidence-informed...

Sexually transmitted infections (STIs), viral hepatitis and cervical cancer are important concerns for any country implementing HIV programmes because...

In 2022, WHO published the Consolidated guidelines on HIV, viral hepatitis and STI prevention, diagnosis, treatment and care for key populations. These...

Key populations (men who have sex with men, people who inject drugs, sex workers, trans and gender diverse people and people in prisons) are at increased...

In 2022, WHO published the Consolidated guidelines on HIV, viral hepatitis and STI prevention, diagnosis, treatment and care for key populations....

In 2022, WHO published the Consolidated guidelines on HIV, viral hepatitis and STI prevention, diagnosis, treatment and care for key populations. These...

Hepatitis C virus (HCV) infection is a major public health problem and cause of chronic liver disease that leads to approximately 399 000 deaths annually....

This guidance document replaces the 2012 WHO position paper on hepatitis A vaccines.Since the publication of the first WHO hepatitis A vaccine position...

The Consolidated guidelines on HIV, viral hepatitis and STI prevention, diagnosis, treatment and care for key populations outline a public health response...

The 2022 Consolidated guidelines on HIV, viral hepatitis and STI prevention, diagnosis, treatment and care for key populations outline a public health...

This policy brief, one of two on the updated hepatitis C (HCV) guidelines, focuses on the new recommendations on simplified service delivery for a public...

This policy brief focuses on the new recommendations on treatment of adolescents and children aged 3 years or older with chronic hepatitis C virus (HCV)...

This document provides interim guidance to countries on testing considerations and strategies for suspect cases of severe acute hepatitis of unknown aetiology...

This document is a list of suggested minimum variables for reporting cases of severe acute hepatitis of unknown aetiology in children to WHO, for the purposes...

WHO has set a global goal to eliminate HCV as a public health problem by 2030. WHO estimates that 58 million people had chronic hepatitis C virus (HCV)...

WHO estimates that in 2015, 257 million people were living with chronic hepatitis B virus (HBV) infection worldwide, and that 900 000 had died from HBV...

WHO estimates that in 2015, 257 million people were living with chronic hepatitis B virus (HBV) infection worldwide, and that 900 000 died from HBV infection,...

WHO estimates that 71 million people worldwide were chronically infected with hepatitis C virus (HCV) in 2017. Globally, 23% of new HCV infections and...

The Consolidated strategic information guidelines for viral hepatitis summarize and simplify the overall approach proposed by WHO to collect,...

These guidelines aim to provide evidence-based recommendations on the care and treatment of persons diagnosed with chronic hepatitis C infection. They...

Hepatitis B virus (HBV) and hepatitis C virus (HCV) infection are major causes of acute and chronic liver disease (e.g. cirrhosis and hepatocellular carcinoma) globally,...

These are the first WHO guidelines on testing for chronic hepatitis B virus (HBV) and hepatitis C virus (HCV) infection and complement published guidance...

In 2010 and 2014, World Health Assembly resolutions called for stronger surveillance of viral hepatitis. In response, the World Health Organization has...

 The field of HCV therapeutics continues to evolve rapidly and, since the World Health Organization (WHO) issued its first Guidelines for the screening,...

 The World Health Organization (WHO) issued the first Guidelines for the screening, care and treatment of persons with hepatitis C infection in...

Injections are one of the most common health care procedures. Every year at least 16 billion injections are administered worldwide. The vast majority –...

Hepatitis B infection is caused by the hepatitis B virus (HBV), an enveloped DNA virus that infects the liver, causing hepatocellular necrosis and inflammation....

These are the first WHO guidelines for the prevention, care and treatment of persons living with chronic hepatitis B (CHB) infection, and complement similar...

These are the first guidelines dealing with hepatitis C treatment produced by the World Health Organization (WHO) and complement existing guidance on the prevention...

 The guidance is the first step in the provision of comprehensive guidance on viral hepatitis surveillance, prevention and treatment by the World...

This field guide is primarily a management guideline for programme managers of immunization services and health workers who provide childhood immunization....